Dr. Yael Gernez-Goldhammer, MD, PhD

Dr. Gernez-Goldhammer practices at Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University.

Dr. Gernez-Goldhammer's NPI, 1659792125, was assigned on December 30, 2013. Dr. Gernez-Goldhammer graduated from Other in 1996. Dr. Gernez-Goldhammer holds California license A133624.

Dr. Gernez-Goldhammer's primary practice is Lucile Packard Children's Hospital Stanford, at 725 Welch Road, Palo Alto, CA 94304 in Santa Clara County. The practice phone is (650) 497-8000.

Dr. Gernez-Goldhammer's primary practice is Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University. Dr. Gernez-Goldhammer is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Gernez-Goldhammer to 1 more medical group, named with a free account. Dr. Gernez-Goldhammer's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gernez-Goldhammer practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Gernez-Goldhammer's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Gernez-Goldhammer is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Gernez-Goldhammer's licenses on file in 2 states: California and New York.

Dmand AI lists immune deficiency disease among the conditions Dr. Gernez-Goldhammer treats.

CMS data shows 13 Medicare services from Dr. Gernez-Goldhammer across 1 procedure code in 2024, for 23 Medicare patients. Medicare paid $948 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 23 Medicare patients who saw Dr. Gernez-Goldhammer in 2024. 70% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gernez-Goldhammer's median patient age at 10, with 42% women.

In 2024, Dr. Gernez-Goldhammer wrote 29 Medicare Part D claims. 59% of them were for generic drugs. They cover 1 drug, with $70,969 in total drug cost. In 2022, CMS named 23 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gernez-Goldhammer for performance year 2024, reported as part of a group. Dr. Gernez-Goldhammer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gernez-Goldhammer as offering telehealth.

CMS Open Payments shows 5 general payments to Dr. Gernez-Goldhammer from 3 drug and device companies from 2016 to 2021. Travel and lodging make up the largest share, 66% of the total. Genentech, Inc. paid the most, $1,224.

Dr. Gernez-Goldhammer graduated from Other in 1996.

Dr. Gernez-Goldhammer is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.